Cardiol Therapeutics
Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a...
Read moreInvestor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a...
Read more(TheNewswire) VANCOUVER September 12, 2025 TheNewswire – Providence Gold Mines Inc. (‘Providence’ or the ‘Company’) is pleased to announce a...
Read moreGold’s record-setting price run continued this week, with yet another new all-time high in the books. Silver also fared well,...
Read moreOn Thursday (September 11), Canadian Prime Minister Mark Carney revealed the first tranche of projects selected by the newly created...
Read moreIn this video, Mary Ellen spotlights the areas driving market momentum following Taiwan Semiconductor’s record-breaking earnings report. She analyzes continued...
Read more